How many drugs treat Sucrase-isomaltase deficiency?

Drug Landscape tracks 3 marketed treatments for Sucrase-isomaltase deficiency (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/sucrase-isomaltase-deficiency.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Sucrase-isomaltase deficiency — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sucrase-isomaltase deficiency (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Sucrase-isomaltase deficiency, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	First approval
Sucraid	SACROSIDASE	Qol Medcl	Sucrose-specific Enzyme [EPC]	1998-01-01
Sucraid	Sucraid	QOL Medical, LLC
Sucrase	Sucrase	University of Miami

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

QOL Medical, LLC · 1 drug in Sucrase-isomaltase deficiency
Qol Medcl · 1 drug in Sucrase-isomaltase deficiency
University of Miami · 1 drug in Sucrase-isomaltase deficiency

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Sucrase-isomaltase deficiency:

Cite this brief

Drug Landscape (2026). Sucrase-isomaltase deficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/sucrase-isomaltase-deficiency. Accessed 2026-06-10.

Sucrase-isomaltase deficiency full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing